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Background
The purpose of this study was to determine the effect of
acute ingestion of a supplement containing primarily beta
alanine, arginine, creatine malate, and glycerol monostea-
rate (MORPH™) on exercise-induced changes in lean mass
of the arms.
Methods
Using a randomized, placebo-controlled, double-blind,
crossover design, eight healthy men (mean ± SD age,
height, weight: 23.6 ± 3.0 y, 180.3 ± 6.9 cm, 81.8 ± 6.9
kg,) were randomly assigned to ingest one serving of
MORPH™, and on a separate day placebo, along with 12
ounces of water. Verification of ingredient purity and
potency by an external laboratory is pending. Thirty min-
utes after consumption, subjects completed a standard-
ized workout for the elbow flexors and extensors (i.e., six
sets × 12–15 reps of biceps curls alternated with six sets ×
12–15 reps of lying triceps extensions). Weight loads, rest
periods between sets, and tempo of execution were tightly
controlled from trial to trial. Body composition was meas-
ured with dual-energy x-ray absorptiometry (DEXA) prior
to supplementation and immediately following the final
set of resistance exercise. Twenty-four hours before each
trial, subjects were required to refrain from exercise and
follow a standardized diet. Data were analyzed via
ANOVA and statistical significance was accepted at P ≤
0.05.
Results
Acute resistance exercise increased the lean mass (LM) of
the arms in both trials (MORPH™: +13.5%; 8807 ± 824
[baseline] to 9999 ± 954 grams [post], placebo: +7.6%;
9066 ± 813 [baseline] to 9753 ± 860 grams [post], P <
0.004), but the increase was significantly greater in
MORPH™ (P < 0.003) (Figure 1). In contrast, no statisti-
cally significant interactions were noted for fat mass or
systemic hemodynamics (heart rate, systolic or diastolic
blood pressure).
Conclusion
Within the framework of the current experimental design,
these preliminary data indicate that acute supplementa-
tion with a product containing primarily beta alanine,
arginine, creatine malate and glycerol monostearate
(MORPH™) augments resistance exercise-induced
increase in lean mass of the arms without negatively
affecting systemic hemodynamics. Future studies should
confirm and refine these results in a larger sample size,
determine the effects of daily supplementation with
MORPH™ on body composition and performance during
prolonged (i.e., 4–8 weeks) resistance training, and clarify
the mechanisms by which this multi-ingredient product
exerts these effects.
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